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Abstract
Background:  Malignant peripheral nerve sheath tumor is a rare soft tissue sarcoma of
ectomesenchymal origin. It is the malignant counterpart of benign soft tissue tumors like
neurofibromas and schwannomas and may often follow them. Common sites include deeper soft
tissues, usually in the proximity of a nerve trunk. Breast is an extremely rare location of this lesion
and presentation as a breast lump in the absence of pain or previous benign neural tumor is even
rarer.
Case presentation: A 38-year-old female presented with complaints of painless, hard breast
lump for three months which was clinically suspected to be a ductal carcinoma with inconclusive
fine needle aspiration cytology. Histopathology revealed a malignant spindle cell tumor which was
confirmed to be malignant peripheral nerve sheath tumor on the basis of immunopositivity for
vimentin, neurone specific enolase and S-100.
Conclusion: To the best of our knowledge only six such case reports have been published in
literature. The differential diagnosis of malignant peripheral nerve sheath tumor should be
considered by the clinician as well as the pathologists in the work-up of a breast neoplasm as
treatment and prognosis of this rare malignancy is different.
Background
Malignant peripheral nerve sheath tumor (MPNST) is a
rare soft tissue sarcoma of the ectomesenchymal origin. It
is the malignant counterpart of benign soft tissue tumors
like neurofibromas and schwannomas and may follow
them. Common sites include deeper soft tissues, usually
in the proximity of a nerve trunk. MPNST in the breast is
often unsuspected and the diagnosis may be missed
unless clinical suspicion is high and immunohistochem-
istry carried out
Case presentation
A 38-year old female patient presented to the surgical out
patient department with complaints of a rapidly growing
right breast lump for three months. There was no history
of prior breast mass, pain, trauma, bleeding, discharge, or
family history of breast cancer. On examination there was
a single 3.5 × 3 × 3 cm, ill defined non tender, firm, fixed
mass in the right upper outer quadrant. There was no
retraction or ulceration of the overlying skin. Fine needle
aspiration cytology (FNAC) suggested a malignant spin-
dle cell tumor probably a malignant phylloides. An exci-
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sional biopsy was advised to confirm the diagnosis and to
guide the further management.
Grossly the specimen was a skin covered lumpectomy
specimen measuring 5 × 4.4 × 4 cms. The cut sections
revealed a firm infiltrative unencapsulated gray white
tumor measuring 3 × 3 × 2.8 cms. There were no slit like
areas, areas of hemorrhage, necrosis or calcification.
Microscopically, Hematoxylin and Eosin (H&E) stained
sections revealed a highly cellular tumor having interven-
ing myxoid areas with streaming of spindle shaped cells
highly suspicious of an MPNST (Figure 1a). The wavy
nuclei and alternating hyper and hypo-cellular areas fur-
ther suggested a tumor of neurogenic origin. Nuclei were
hyperchromatic and pleomorphic with abundant mitoses.
There were no entrapped epithelial elements (Figure 2). A
provisional diagnosis of malignant spindle cell sarcoma
was made. Immunohistochemistry was done to categorize
the tumor. The tumor cells were also positive for neuron
specific enolase (NSE) and Vimentin. S-100 was diffusely
positive in the tumor cells confirming the neural nature of
tumor and the final diagnosis of MPNST was made. (Fig-
ure 1b)
Discussion
Malignant peripheral nerve sheath tumor (MPNST) is the
preferred term for tumors originating from peripheral
nerves or from cells associated with the nerve sheath, such
as Schwann cells, perineural cells replacing previous enti-
ties such as malignant schwannoma, malignant neurilem-
moma and neurofibrosarcoma. They represent
approximately 10% of all soft tissue sarcomas [1]. MPN-
STs commonly arise in adult patients ranging from 20 to
50 years of age. They originate from a major or minor
peripheral nerve branch or its sheath. The common sites
of origin include the extremities and trunk usually sciatic
nerve, brachial plexus and the sacral plexus. Most cases
average more than 5 cm in diameter [2]. They may arise
spontaneously, although in 5% to 42% of cases an associ-
ation with Neurofibromatosis (NF) Type 1 is known.
Deeper neurofibromas are more likely to undergo malig-
nant transformation rather their superficial counterparts
in NF Type 1 [3]. MPNST of the breast is very rare and has
been reported only twice in English literature and a total
of six case reports in the extensively searched medical lit-
erature till date [4-9].
MPNST have to be distinguished from malignant phyl-
loides, fibrosarcoma and leiomyosarcoma. Malignant
phylloides shows features reminiscent of phylloides
tumor, with compressed epithelium lined leaf like spaces,
which were absent in the present case despite exhaustive
sampling of the tumor. MPNST closely resembles fibrosa-
rcoma morphologically. MPNST is comprised of spindle
cells arranged in dense cellular areas interspersed with
hypocellular myxoid areas and these cells show wavy
nuclear contours which helps in excluding a fibrosar-
coma. On the other hand, spindle cells of the leiomyosa-
rcoma have a more distinct eosinophilic cytoplasm and a
blunted nucleus compared to those of MPNST thus ruling
out the diagnosis in this case. Distinguishing the MPNST
from a benign nerve sheath tumor may be challenging
too, as occasional neurofibromas may be quite cellular
and contain occasional pleomorphic cells but presence of
high mitotic activity was the determining feature in our
case [1].
Hyperchromatic and pleomorphic wavy nuclei with mitoses Figure 2
Hyperchromatic and pleomorphic wavy nuclei with mitoses. 
(H&E ×400)
a. Alternating hyper and hypocellular areas of tumor with  palisading spindle shaped cells and intervening myxoid areas  (H&E ×200) Figure 1
a. Alternating hyper and hypocellular areas of tumor with 
palisading spindle shaped cells and intervening myxoid areas 
(H&E ×200). Cells are diffusely positive for S-100 (b) (Immu-
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The MPNST is classified into three types – epithelioid,
mesenchymal (including Triton tumor) and glandular
variants. The epithelioid variant demonstrates plump,
rounded cells scattered in lesion, usually in rather small
numbers or in well defined clusters as seen in our case
[10].
Immunostaining shows focal staining for S-100, CD57
and Leu-7 and myelin basic protein in 50% of the cases.
The present case expressed diffuse and strong positivity for
S100 confirming the diagnosis [11]. MPNST in most
instances has a poor 5 year survival rate. Treatment is
complete surgical excision of the tumor with negative
margins along with radiotherapy for best outcome with
respect to local recurrence and distant metastases. Dissec-
tion of axillary tail is not the protocol as the mode of dis-
semination is primarily hematogenous and not through
the axillary lymph nodes [12].
Conclusion
Our case of MPNST is unique because of its rare location.
We report the seventh case of MPNST of the breast. Also
the patient had no pain at the time of presentation and no
history of long standing preceding neurofibromas was
present. On extensive examination there were no subcuta-
neous swellings, café au lait spots or Lisch nodules ruling
out underlying Neurofibromatosis.
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